Innometry Co. Ltd (302430) — Capital Reinvestment Ratio
Latest as of September 2025:
0.61x
Innometry Co. Ltd (302430) has a Capital Reinvestment Ratio of 0.61x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.20 Billion) in capital expenditures (₩735.41 Million). See 302430 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.61x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.20 Billion
KRW
Capital Expenditures
₩735.41 Million
KRW
Data as of
Sep 2025
Most recent filing
Innometry Co. Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Innometry Co. Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Innometry Co. Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Innometry Co. Ltd from 2016 to 2024. For live market cap and broader valuation context, see Innometry Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | ₩14.76 Billion | ₩1.95 Billion | ▼ -79.7% |
| 2022 | 0.65x | ₩3.84 Billion | ₩2.51 Billion | ▼ -53.3% |
| 2020 | 1.40x | ₩4.45 Billion | ₩6.21 Billion | ▼ -56.2% |
| 2018 | 3.19x | ₩1.69 Billion | ₩5.39 Billion | ▲ +230598.8% |
| 2017 | 0.00x | ₩3.12 Billion | ₩4.31 Million | ▼ -97.9% |
| 2016 | 0.07x | ₩1.30 Billion | ₩87.23 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow